Hap Trading, LLC Mannkind Corp Put Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 12, 2023	SELL	$3.95 - $5.63 $5,135 - $7,319	-1,300 Reduced 9.63%	12,200 $11,000
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $40,770 - $72,495	13,500 New	13,500 $7,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $27,945 - $37,053	6,900 Added 33.66%	27,400 $16,000
Q3 2021 Nov 10, 2021	BUY	$3.89 - $5.48 $8,947 - $12,604	2,300 Added 12.64%	20,500 $25,000
Q2 2021 Aug 11, 2021	SELL	$3.61 - $5.45 $18,411 - $27,795	-5,100 Reduced 21.89%	18,200 $14,000
Q1 2021 May 14, 2021	SELL	$3.14 - $6.14 $37,680 - $73,680	-12,000 Reduced 33.99%	23,300 $34,000
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $37,590 - $84,840	21,000 Added 146.85%	35,300 $41,000
Q3 2020 Nov 13, 2020	SELL	$1.56 - $2.08 $7,956 - $10,608	-5,100 Reduced 26.29%	14,300 $2,000
Q2 2020 Aug 10, 2020	SELL	$0.94 - $2.21 $6,862 - $16,133	-7,300 Reduced 27.34%	19,400 $7,000
Q1 2020 May 08, 2020	BUY	$0.84 - $1.76 $22,428 - $46,992	26,700 New	26,700 $19,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.